Duration of Clopidogrel Therapy Following Treatment With the Zotarolimus-Eluting Stent in Real
World Clinical Practice; PRODIGY, Prolonging Dual Antiplatelet Treatment After Grading StentInduced Intimal Hyperplasia Study; RESET, REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation; SECURITY, Second Generation Drug-Eluting Stent Implantation Followed by Six-Versus Twelve-Month Dual Antiplatelet Therapy; ARCTIC-Interruption, Assessment by a double Randomisation of a Conventional antiplatelet strategy versus a monitoring-guided strategy for drug-eluting stent implantation and, of Treatment Interruption versus Continuation 1 year after stenting)-Interruption; DES-LATE, Optimal Duration of Clopidogrel Therapy With DES to Reduce Late Coronary Arterial Thrombotic Event.
Web figure 10. Individual and summary odds for TIMI major bleeding events stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy; TIMI, thrombolysis in myocardial infarction. Other abbreviations as in eFigure 9.
Web figure 11. Individual and summary odds for MACCE (major adverse cardiac and cerebrovascular events) stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 12.
Post-randomisation analysis of individual and summary odds for the endpoint of cardiovascular mortality stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 13. Post-randomisation analysis of individual and summary odds for myocardial infarction stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 14. Post-randomisation analysis of individual and summary odds for definite/probable stent thrombosis stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 15. Post-randomisation analysis of individual and summary odds for definite stent thrombosis stratified by short-term (<12 months) vs 12 months and long-term (>12 months) vs 12 months DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 16. Post-randomisation analysis of individual and summary odds for late and very late stent thrombosis. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 17. Post-randomisation analysis of individual and summary odds for major bleeding stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9.
Web figure 18. Post-randomisation analysis of individual and summary odds for all-cause mortality stratified by short-term vs 12-month and extended vs 12-month DAPT regimen. DAPT, dual antiplatelet therapy. Other abbreviations as in eFigure 9. Tables  Web table 1 
